FDA Starts Releasing Thousands of Pfizer COVID-19 Vaccine Documents
The FDA has begun releasing a court-mandated trove of documents pertaining to the agency’s review of Pfizer/BioNTech’s COVID-19 vaccine — which the agency authorized for emergency use in December 2020 before granting full approval in August 2021.
Login
Subscribe To FDAnews
Upcoming Events
Featured Products
From QSR to QMSR: Meeting FDA’s New Requirements
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
